ClinicalTrials.Veeva
Menu

Find clinical trials for Adenocarcinoma in San Diego, CA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Carcinoma
Cancer
Pancreatic Cancer
Colorectal Cancer
Stomach Cancer
Esophageal Cancer
Non-Small-Cell Lung Carcinoma

Adenocarcinoma trials near San Diego, CA, USA:

A Study of ACR-368 in Ovarian Carcinoma, Endometrial Adenocarcinoma, and Urothelial Carcinoma

participants with platinum-resistant ovarian carcinoma, endometrial adenocarcinoma, and urothelial carcinoma based on Acrivon's OncoSignatur...

Enrolling
Endometrial Adenocarcinoma
Urothelial Carcinoma
Drug: ACR-368
Diagnostic Test: OncoSignature

Phase 1, Phase 2

Acrivon Therapeutics

La Jolla, California, United States and 67 other locations

This research study is studying a combination of hormonal therapy, chemotherapy, and immunotherapy as a possible treatment for metastatic hormone-sen...

Active, not recruiting
Metastasis Prostate Adenocarcinoma
Prostate Adenocarcinoma
Drug: Docetaxel
Drug: Nivolumab

Phase 2

Xiao X. Wei, MD

La Jolla, California, United States and 5 other locations

This is a first-in-human, open-label, non-randomized, three-part phase 1 trial of INBRX-109, which is a recombinant humanized tetravalent antibody ta...

Enrolling
Colorectal Adenocarcinoma
Pancreatic Adenocarcinoma
Drug: 5-fluorouracil
Drug: Carboplatin

Phase 1

Inhibrx

San Diego, California, United States and 18 other locations

will help in treating patients with Locally Advanced Unresectable or Metastatic HER2-Positive Gastric or Gastroesophageal Junction (G/GEJ) Adenocarcinoma...

Active, not recruiting
Metastatic HER2 Positive Gastroesophageal Junction Cancer
Biological: CYNK-101
Drug: Fludarabine

Phase 1, Phase 2

Celularity

La Jolla, California, United States and 2 other locations

This research is designed to determine if experimental treatment with Antibody-drug conjugate, AZD5335, alone, or in combination with anti-cancer age...

Enrolling
Lung Adenocarcinoma
Ovarian Cancer
Drug: AZD5305
Drug: AZD5335

Phase 1, Phase 2

AstraZeneca
AstraZeneca

La Jolla, California, United States and 38 other locations

The purpose of the dose escalation phase is to evaluate the safety profile of escalating doses and dose schedules of NXP800. In the expansion phase t...

Enrolling
Ovarian Clear Cell Adenocarcinoma
Ovarian Endometrioid Adenocarcinoma
Drug: NXP800

Phase 1

Nuvectis Pharma

La Jolla, California, United States and 21 other locations

designed to examine the effects of AZD0171 and durvalumab in combination with standard-of-care chemotherapy in patients with pancreatic ductal adenocarcinoma...

Active, not recruiting
Locally Advanced or Metastatic Solid Tumours
Drug: Nab-paclitaxel
Drug: Durvalumab

Phase 2

AstraZeneca
AstraZeneca

La Jolla, California, United States and 33 other locations

The ProVent study is a randomized, open-label study designed to assess the efficacy of sipuleucel-T in reducing the progression of lower risk non-met...

Active, not recruiting
Adenocarcinoma of the Prostate
Biological: sipuleucel-T

Phase 3

Dendreon

La Jolla, California, United States and 55 other locations

A Phase 1/2 study to evaluate the safety and efficacy of ARV-766 given by mouth alone or in combination with abiraterone in men with metastatic prost...

Enrolling
Prostate Cancer Metastatic
Drug: ARV-766 + Abiraterone Part C&D
Drug: ARV-766 Part A&B

Phase 1, Phase 2

Arvinas
Arvinas

La Jolla, California, United States and 22 other locations

The main objective of this study is to compare efficacy of bemarituzumab combined with oxaliplatin, leucovorin, and 5-fluorouracil (5-FU) (mFOLFOX6)...

Active, not recruiting
Gastroesophageal Junction Adenocarcinoma
Gastric Cancer
Drug: Bemarituzumab
Drug: mFOLFOX6

Phase 3

Amgen
Amgen

Tijuana, Baja California Norte, Mexico and 300 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems